BEIJING (Reuters) – Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker. Read full story
Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development
